Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism

Chronic heart failure is one of the leading causes of death globally, affecting 1.5 to 2% of the total world population and 2.9 to 3.9% of the total Western European population. Chronic heart failure often progresses rapidly in coexistence with endocrine pathology, namely hypothyroidism, that result...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Farmacija 2022-01, Vol.69 (1), p.31-35
Hauptverfasser: Mykula, Yuliia Ihorivna, Kupnovytska, Iryna Hryhorivna, Danulyk, Oksana Ihorivna
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 35
container_issue 1
container_start_page 31
container_title Farmacija
container_volume 69
creator Mykula, Yuliia Ihorivna
Kupnovytska, Iryna Hryhorivna
Danulyk, Oksana Ihorivna
description Chronic heart failure is one of the leading causes of death globally, affecting 1.5 to 2% of the total world population and 2.9 to 3.9% of the total Western European population. Chronic heart failure often progresses rapidly in coexistence with endocrine pathology, namely hypothyroidism, that results in a more rapid development and further progression of endothelial dysfunction and the development of a systemic inflammatory response. The aim of our research was to study the levels of endothelin-1, C-reactive protein, tumor necrosis factor α and their correlation with the levels of thyroid-stimulating hormone, thyroxine in patients with chronic heart failure and coexisting hypothyroidism. There were examined 38 patients with chronic heart failure and coexisting hypothyroidism and 42 patients with chronic heart failure without hypothyroidism. The serum levels of endothelin-1, C-reactive protein, tumor necrosis factor α were determined by the enzyme-linked immunosorbent assay, while the levels of thyroid-stimulating hormone and thyroxine were determined by the electrochemiluminescence immunoassay. In patients with chronic heart failure and coexisting hypothyroidism, the levels of endothelin-1, C-reactive protein, and tumor necrosis factor α were 2.9, 1.5 and 2.27 times higher than those in patients without hypothyroidism. In Group I, there was a moderate positive correlation between the serum levels of endothelin-1 and thyroid-stimulating hormone and a weak negative correlation between the levels of thyroxine and endothelin-1. In Group II, there was a weak correlation between the levels of endothelin-1 and thyroid-stimulating hormone and no correlation between the levels of thyroxine and endothelin-1. In Group I, there was a strong positive correlation between C-reactive protein and thyroid-stimulating hormone levels as well; in Group II, no similar correlation was found. In Group I, there was found a moderate negative correlation between tumor necrosis factor α and thyroxine levels. According to our results, there was a close correlation between the markers of endothelial dysfunction, immune inflammatory response, and single markers of hypothyroidism.
doi_str_mv 10.3897/pharmacia.69.e77225
format Article
fullrecord <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3897_pharmacia_69_e77225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_93b09947741046c7898a7d87456ed739</doaj_id><sourcerecordid>oai_doaj_org_article_93b09947741046c7898a7d87456ed739</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-73393be7dde3236af0fb8b85f7d207622e63ee69350ceb03a43000c133a2c9703</originalsourceid><addsrcrecordid>eNo9kc2K3DAQhEVIIMNknyAXvYAnsmTr5xiW_Aws5JJAbqJHaq212JKRNCTzKHnbeHaWPTUU1FfVFCEfe3YQ2qhP6wRlARfhIM0BleJ8fEN2XDLRjaP6_Zbs2MB1x7iR78ldrU-MMa6ZNlzvyL9j8tFBy6XSHCgmn9uEc4SZhnNyLeZEIXlaL7XhEh2Ny3JOSGMKMyzL1XihBeuaU72qdIUWMbVK_8Q2UTeVnDbXhFAaDRDnc8FnoMv4N9YW0yNdS1xgw0yXdQu_lBx9rMsH8i7AXPHu5e7Jr69fft5_7x5-fDvef37onOhZ65QQRpxQeY-CCwmBhZM-6TEoz5mSnKMUiNKIkTk8MQGD2P53vRDAnVFM7MnxxvUZnuxLF5sh2mchl0e7dY9uRrsFMWMGpYaeDdIpbTQor9UwSvRq67En4sZyJddaMLzyemavY9nXsaw09jaW-A9t0Y75</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mykula, Yuliia Ihorivna ; Kupnovytska, Iryna Hryhorivna ; Danulyk, Oksana Ihorivna</creator><creatorcontrib>Mykula, Yuliia Ihorivna ; Kupnovytska, Iryna Hryhorivna ; Danulyk, Oksana Ihorivna</creatorcontrib><description>Chronic heart failure is one of the leading causes of death globally, affecting 1.5 to 2% of the total world population and 2.9 to 3.9% of the total Western European population. Chronic heart failure often progresses rapidly in coexistence with endocrine pathology, namely hypothyroidism, that results in a more rapid development and further progression of endothelial dysfunction and the development of a systemic inflammatory response. The aim of our research was to study the levels of endothelin-1, C-reactive protein, tumor necrosis factor α and their correlation with the levels of thyroid-stimulating hormone, thyroxine in patients with chronic heart failure and coexisting hypothyroidism. There were examined 38 patients with chronic heart failure and coexisting hypothyroidism and 42 patients with chronic heart failure without hypothyroidism. The serum levels of endothelin-1, C-reactive protein, tumor necrosis factor α were determined by the enzyme-linked immunosorbent assay, while the levels of thyroid-stimulating hormone and thyroxine were determined by the electrochemiluminescence immunoassay. In patients with chronic heart failure and coexisting hypothyroidism, the levels of endothelin-1, C-reactive protein, and tumor necrosis factor α were 2.9, 1.5 and 2.27 times higher than those in patients without hypothyroidism. In Group I, there was a moderate positive correlation between the serum levels of endothelin-1 and thyroid-stimulating hormone and a weak negative correlation between the levels of thyroxine and endothelin-1. In Group II, there was a weak correlation between the levels of endothelin-1 and thyroid-stimulating hormone and no correlation between the levels of thyroxine and endothelin-1. In Group I, there was a strong positive correlation between C-reactive protein and thyroid-stimulating hormone levels as well; in Group II, no similar correlation was found. In Group I, there was found a moderate negative correlation between tumor necrosis factor α and thyroxine levels. According to our results, there was a close correlation between the markers of endothelial dysfunction, immune inflammatory response, and single markers of hypothyroidism.</description><identifier>ISSN: 0428-0296</identifier><identifier>EISSN: 2603-557X</identifier><identifier>DOI: 10.3897/pharmacia.69.e77225</identifier><language>eng</language><publisher>Pensoft Publishers</publisher><ispartof>Farmacija, 2022-01, Vol.69 (1), p.31-35</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c310t-73393be7dde3236af0fb8b85f7d207622e63ee69350ceb03a43000c133a2c9703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Mykula, Yuliia Ihorivna</creatorcontrib><creatorcontrib>Kupnovytska, Iryna Hryhorivna</creatorcontrib><creatorcontrib>Danulyk, Oksana Ihorivna</creatorcontrib><title>Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism</title><title>Farmacija</title><description>Chronic heart failure is one of the leading causes of death globally, affecting 1.5 to 2% of the total world population and 2.9 to 3.9% of the total Western European population. Chronic heart failure often progresses rapidly in coexistence with endocrine pathology, namely hypothyroidism, that results in a more rapid development and further progression of endothelial dysfunction and the development of a systemic inflammatory response. The aim of our research was to study the levels of endothelin-1, C-reactive protein, tumor necrosis factor α and their correlation with the levels of thyroid-stimulating hormone, thyroxine in patients with chronic heart failure and coexisting hypothyroidism. There were examined 38 patients with chronic heart failure and coexisting hypothyroidism and 42 patients with chronic heart failure without hypothyroidism. The serum levels of endothelin-1, C-reactive protein, tumor necrosis factor α were determined by the enzyme-linked immunosorbent assay, while the levels of thyroid-stimulating hormone and thyroxine were determined by the electrochemiluminescence immunoassay. In patients with chronic heart failure and coexisting hypothyroidism, the levels of endothelin-1, C-reactive protein, and tumor necrosis factor α were 2.9, 1.5 and 2.27 times higher than those in patients without hypothyroidism. In Group I, there was a moderate positive correlation between the serum levels of endothelin-1 and thyroid-stimulating hormone and a weak negative correlation between the levels of thyroxine and endothelin-1. In Group II, there was a weak correlation between the levels of endothelin-1 and thyroid-stimulating hormone and no correlation between the levels of thyroxine and endothelin-1. In Group I, there was a strong positive correlation between C-reactive protein and thyroid-stimulating hormone levels as well; in Group II, no similar correlation was found. In Group I, there was found a moderate negative correlation between tumor necrosis factor α and thyroxine levels. According to our results, there was a close correlation between the markers of endothelial dysfunction, immune inflammatory response, and single markers of hypothyroidism.</description><issn>0428-0296</issn><issn>2603-557X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kc2K3DAQhEVIIMNknyAXvYAnsmTr5xiW_Aws5JJAbqJHaq212JKRNCTzKHnbeHaWPTUU1FfVFCEfe3YQ2qhP6wRlARfhIM0BleJ8fEN2XDLRjaP6_Zbs2MB1x7iR78ldrU-MMa6ZNlzvyL9j8tFBy6XSHCgmn9uEc4SZhnNyLeZEIXlaL7XhEh2Ny3JOSGMKMyzL1XihBeuaU72qdIUWMbVK_8Q2UTeVnDbXhFAaDRDnc8FnoMv4N9YW0yNdS1xgw0yXdQu_lBx9rMsH8i7AXPHu5e7Jr69fft5_7x5-fDvef37onOhZ65QQRpxQeY-CCwmBhZM-6TEoz5mSnKMUiNKIkTk8MQGD2P53vRDAnVFM7MnxxvUZnuxLF5sh2mchl0e7dY9uRrsFMWMGpYaeDdIpbTQor9UwSvRq67En4sZyJddaMLzyemavY9nXsaw09jaW-A9t0Y75</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Mykula, Yuliia Ihorivna</creator><creator>Kupnovytska, Iryna Hryhorivna</creator><creator>Danulyk, Oksana Ihorivna</creator><general>Pensoft Publishers</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20220101</creationdate><title>Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism</title><author>Mykula, Yuliia Ihorivna ; Kupnovytska, Iryna Hryhorivna ; Danulyk, Oksana Ihorivna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-73393be7dde3236af0fb8b85f7d207622e63ee69350ceb03a43000c133a2c9703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mykula, Yuliia Ihorivna</creatorcontrib><creatorcontrib>Kupnovytska, Iryna Hryhorivna</creatorcontrib><creatorcontrib>Danulyk, Oksana Ihorivna</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Farmacija</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mykula, Yuliia Ihorivna</au><au>Kupnovytska, Iryna Hryhorivna</au><au>Danulyk, Oksana Ihorivna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism</atitle><jtitle>Farmacija</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>69</volume><issue>1</issue><spage>31</spage><epage>35</epage><pages>31-35</pages><issn>0428-0296</issn><eissn>2603-557X</eissn><abstract>Chronic heart failure is one of the leading causes of death globally, affecting 1.5 to 2% of the total world population and 2.9 to 3.9% of the total Western European population. Chronic heart failure often progresses rapidly in coexistence with endocrine pathology, namely hypothyroidism, that results in a more rapid development and further progression of endothelial dysfunction and the development of a systemic inflammatory response. The aim of our research was to study the levels of endothelin-1, C-reactive protein, tumor necrosis factor α and their correlation with the levels of thyroid-stimulating hormone, thyroxine in patients with chronic heart failure and coexisting hypothyroidism. There were examined 38 patients with chronic heart failure and coexisting hypothyroidism and 42 patients with chronic heart failure without hypothyroidism. The serum levels of endothelin-1, C-reactive protein, tumor necrosis factor α were determined by the enzyme-linked immunosorbent assay, while the levels of thyroid-stimulating hormone and thyroxine were determined by the electrochemiluminescence immunoassay. In patients with chronic heart failure and coexisting hypothyroidism, the levels of endothelin-1, C-reactive protein, and tumor necrosis factor α were 2.9, 1.5 and 2.27 times higher than those in patients without hypothyroidism. In Group I, there was a moderate positive correlation between the serum levels of endothelin-1 and thyroid-stimulating hormone and a weak negative correlation between the levels of thyroxine and endothelin-1. In Group II, there was a weak correlation between the levels of endothelin-1 and thyroid-stimulating hormone and no correlation between the levels of thyroxine and endothelin-1. In Group I, there was a strong positive correlation between C-reactive protein and thyroid-stimulating hormone levels as well; in Group II, no similar correlation was found. In Group I, there was found a moderate negative correlation between tumor necrosis factor α and thyroxine levels. According to our results, there was a close correlation between the markers of endothelial dysfunction, immune inflammatory response, and single markers of hypothyroidism.</abstract><pub>Pensoft Publishers</pub><doi>10.3897/pharmacia.69.e77225</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0428-0296
ispartof Farmacija, 2022-01, Vol.69 (1), p.31-35
issn 0428-0296
2603-557X
language eng
recordid cdi_crossref_primary_10_3897_pharmacia_69_e77225
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
title Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indicators%20of%20endothelial%20function%20and%20systemic%20immune%20inflammatory%20response%20in%20patients%20with%20chronic%20heart%20failure%20and%20coexisting%20primary%20hypothyroidism&rft.jtitle=Farmacija&rft.au=Mykula,%20Yuliia%20Ihorivna&rft.date=2022-01-01&rft.volume=69&rft.issue=1&rft.spage=31&rft.epage=35&rft.pages=31-35&rft.issn=0428-0296&rft.eissn=2603-557X&rft_id=info:doi/10.3897/pharmacia.69.e77225&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_93b09947741046c7898a7d87456ed739%3C/doaj_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_doaj_id=oai_doaj_org_article_93b09947741046c7898a7d87456ed739&rfr_iscdi=true